CLOV — Clover Health Investments Cashflow Statement
0.000.00%
Last trade - 00:00- $1.64bn
- $1.52bn
- $1.92bn
Annual cashflow statement for Clover Health Investments, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -588 | -340 | -213 | -43 | -85.5 |
| Depreciation | |||||
| Non-Cash Items | 112 | 137 | 40.9 | 63.7 | 101 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 193 | -2.36 | 25.3 | 12.9 | -84.2 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -282 | -204 | -145 | 34.8 | -66.9 |
| Capital Expenditures | -0.723 | -4.47 | -0.584 | -1.56 | -2.04 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -435 | 99.6 | 141 | 2.12 | 6.12 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -435 | 95.1 | 140 | 0.565 | 4.08 |
| Financing Cash Flow Items | 666 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 925 | -4.96 | -5.07 | -17.4 | -53.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 208 | -114 | -9.72 | 18 | -116 |